Literature DB >> 21252211

Commentary: Co-occurrence of tuberculosis and diabetes: new paradigm of epidemiological transition.

Matthew J Magee1, Henry M Blumberg, K M Venkat Narayan.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21252211     DOI: 10.1093/ije/dyq268

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  5 in total

1.  Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru.

Authors:  M J Magee; E Bloss; S S Shin; C Contreras; H Arbanil Huaman; J Calderon Ticona; J Bayona; C Bonilla; M Yagui; O Jave; J P Cegielski
Journal:  Int J Infect Dis       Date:  2013-02-22       Impact factor: 3.623

2.  Burden of diabetes among patients with tuberculosis: 10-year experience from a tertiary care referral teaching hospital in South India.

Authors:  Devasahayam Jesudas Christopher; Lakshmanan Jeyaseelan; Joy Sarojini Michael; Balaji Veeraraghavan; Marie Therese Manipadam; Thambu David; Mayank Gupta; Bijesh Yadav
Journal:  Lung India       Date:  2020 May-Jun

3.  Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: A prospective cohort study.

Authors:  Fatima Mukhtar; Zahid A Butt
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

4.  Tuberculosis and Diabetes in India: Stakeholder Perspectives on Health System Challenges and Opportunities for Integrated Care.

Authors:  Shaffi Fazaludeen Koya; Jinbert Lordson; Salman Khan; Binod Kumar; Chitra Grace; K Rajasekharan Nayar; Vinod Kumar; Anand M Pillai; Lal S Sadasivan; A Marthanda Pillai; Abu S Abdullah
Journal:  J Epidemiol Glob Health       Date:  2022-01-10

5.  Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.

Authors:  Matthew J Magee; Russell R Kempker; Maia Kipiani; Nestani Tukvadze; Penelope P Howards; K M Venkat Narayan; Henry M Blumberg
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.